La FDA aprueba el primer antiviral de ingestión oral para el tratamiento del COVID-19 en adultos

In English SILVER SPRING, Md., 26 de mayo de 2023 /PRNewswire-HISPANIC PR WIRE/ — La Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó el antiviral de ingestión oral Paxlovid (tabletas de nirmatrelvir y tabletas de ritonavir,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.